-
Mashup Score: 26Superstition in Surgery: A Population-Based Cohort Study to ... : Annals of Surgery Open - 3 month(s) ago
time of surgery can lead to worse outcomes. Superstitious patients often express significant concern and anxiety when undergoing a surgical procedure on Friday the 13th. Methods: A retrospective, population-based cohort study of 19,747 adults undergoing 1 of 25 common surgical procedures on Friday the 13th or flanking control Fridays (Friday the 6th and Friday the 20th) between January 1, 2007, and December 31, 2019, with 1 year of follow-up. The main outcomes included death, readmission, and complications at 30 days (short-term), 90 days (intermediate-term), and 1 year (long-term). Results: A total of 7,349 (37.2%) underwent surgery on Friday the 13th, and 12,398 (62.8%) underwent surgery on a flanking Friday during the study period. Patient characteristics were similar between the 2 groups. We found no evidence that patients receiving surgery on Friday the 13th group were more likely to experience the composite primary outcome at 30 days [adjusted odds ratio (aOR) = 1.02 (95% CI = 0.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Superstition in Surgery: A Population-Based Cohort Study to ... : Annals of Surgery Open - 3 month(s) ago
time of surgery can lead to worse outcomes. Superstitious patients often express significant concern and anxiety when undergoing a surgical procedure on Friday the 13th. Methods: A retrospective, population-based cohort study of 19,747 adults undergoing 1 of 25 common surgical procedures on Friday the 13th or flanking control Fridays (Friday the 6th and Friday the 20th) between January 1, 2007, and December 31, 2019, with 1 year of follow-up. The main outcomes included death, readmission, and complications at 30 days (short-term), 90 days (intermediate-term), and 1 year (long-term). Results: A total of 7,349 (37.2%) underwent surgery on Friday the 13th, and 12,398 (62.8%) underwent surgery on a flanking Friday during the study period. Patient characteristics were similar between the 2 groups. We found no evidence that patients receiving surgery on Friday the 13th group were more likely to experience the composite primary outcome at 30 days [adjusted odds ratio (aOR) = 1.02 (95% CI = 0.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet-
Superstition in Surgery - Should we operate on Friday the 13th? https://t.co/wKhqxm3PAH @SanjanaR2024 @WallisCJD
-
-
Mashup Score: 26Superstition in Surgery: A Population-Based Cohort Study to ... : Annals of Surgery Open - 3 month(s) ago
time of surgery can lead to worse outcomes. Superstitious patients often express significant concern and anxiety when undergoing a surgical procedure on Friday the 13th. Methods: A retrospective, population-based cohort study of 19,747 adults undergoing 1 of 25 common surgical procedures on Friday the 13th or flanking control Fridays (Friday the 6th and Friday the 20th) between January 1, 2007, and December 31, 2019, with 1 year of follow-up. The main outcomes included death, readmission, and complications at 30 days (short-term), 90 days (intermediate-term), and 1 year (long-term). Results: A total of 7,349 (37.2%) underwent surgery on Friday the 13th, and 12,398 (62.8%) underwent surgery on a flanking Friday during the study period. Patient characteristics were similar between the 2 groups. We found no evidence that patients receiving surgery on Friday the 13th group were more likely to experience the composite primary outcome at 30 days [adjusted odds ratio (aOR) = 1.02 (95% CI = 0.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet-
Superstition in Surgery - Should we operate on Friday the 13th? https://t.co/wKhqxm3PAH @SanjanaR2024 @WallisCJD
-
-
Mashup Score: 26Superstition in Surgery: A Population-Based Cohort Study to ... : Annals of Surgery Open - 3 month(s) ago
time of surgery can lead to worse outcomes. Superstitious patients often express significant concern and anxiety when undergoing a surgical procedure on Friday the 13th. Methods: A retrospective, population-based cohort study of 19,747 adults undergoing 1 of 25 common surgical procedures on Friday the 13th or flanking control Fridays (Friday the 6th and Friday the 20th) between January 1, 2007, and December 31, 2019, with 1 year of follow-up. The main outcomes included death, readmission, and complications at 30 days (short-term), 90 days (intermediate-term), and 1 year (long-term). Results: A total of 7,349 (37.2%) underwent surgery on Friday the 13th, and 12,398 (62.8%) underwent surgery on a flanking Friday during the study period. Patient characteristics were similar between the 2 groups. We found no evidence that patients receiving surgery on Friday the 13th group were more likely to experience the composite primary outcome at 30 days [adjusted odds ratio (aOR) = 1.02 (95% CI = 0.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet-
Superstition in Surgery - Should we operate on Friday the 13th? https://t.co/wKhqxm3PAH @SanjanaR2024 @WallisCJD
-
-
Mashup Score: 26Superstition in Surgery: A Population-Based Cohort Study to ... : Annals of Surgery Open - 3 month(s) ago
time of surgery can lead to worse outcomes. Superstitious patients often express significant concern and anxiety when undergoing a surgical procedure on Friday the 13th. Methods: A retrospective, population-based cohort study of 19,747 adults undergoing 1 of 25 common surgical procedures on Friday the 13th or flanking control Fridays (Friday the 6th and Friday the 20th) between January 1, 2007, and December 31, 2019, with 1 year of follow-up. The main outcomes included death, readmission, and complications at 30 days (short-term), 90 days (intermediate-term), and 1 year (long-term). Results: A total of 7,349 (37.2%) underwent surgery on Friday the 13th, and 12,398 (62.8%) underwent surgery on a flanking Friday during the study period. Patient characteristics were similar between the 2 groups. We found no evidence that patients receiving surgery on Friday the 13th group were more likely to experience the composite primary outcome at 30 days [adjusted odds ratio (aOR) = 1.02 (95% CI = 0.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet-
Superstition in Surgery - Should we operate on Friday the 13th? https://t.co/wKhqxm3PAH @SanjanaR2024 @WallisCJD
-
-
Mashup Score: 0
Physician Assistant – Urology (Medical Center) job
Source: www.houstonmethodistcareers.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
We are hiring a Hybrid PA: 50% Clinical (Urologic Oncology) and 50% Research - Unique opportunity to be a Co-Investigator on Clinical Trials. Oncology/Research background a plus. https://t.co/aYJERVaMAR @KKseattle @JADPRO @APSHOorg @PAJobSite @RRGonzalezMD @DharamKaushik5
-
-
Mashup Score: 0Post Doc 2023.pdf - 1 year(s) ago
Shared with Dropbox
Source: DropboxCategories: Hem/Oncs, Latest HeadlinesTweet-
Open Position: 1-year Urologic Oncology and Health Services Research Fellowship (Funded) @ @MethodistHosp HSR Methods, Clinical Epi, Surgical Outcomes. https://t.co/pSaEa67Kzp @Uro_Res @KKseattle @HMethodistMD @HMethodistUro @RRGonzalezMD @AmerUrological @UroAcademic
-
-
Mashup Score: 3Adjuvant Immunotherapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis - PubMed - 1 year(s) ago
The evidence base to date regarding ICI as adjuvant therapy in RCC is mixed – conclusions are limited by considerable heterogeneity between studies. However, pooled analyses suggest that patients with positive PD-L1 expression or sarcomatoid features are most likely to benefit from adjuvant immunoth …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Adjuvant Immunotherapy in Renal Cell Carcinoma - Meta Analysis https://t.co/PIgDxKEeVi Clinical and statistical heterogeneity limit conclusions. Signal for PD-L1 + and sarcomatoid subgroups? @WallisCJD @CarlosARiverosS @brian_rini @DrChoueiri @tompowles1 @allaf_mo @montypal
-
-
Mashup Score: 9
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Proud of our team - First Patient in Texas to receive intravesical UGN-102 as part of the ENVISION Clinical Trial for Low Grade Intermediate Risk NMIBC #bladder cancer @BladderCancerUS @UroGenPharma @HMethodistUro @HMethodistMD @EfstathiouEleni https://t.co/BllPkxgj6T https://t.co/wEsqTx8FEg
-
-
Mashup Score: 7
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Landmark step at @HMethodistUro w/ Registration of 1st pt - RAD VACCINE MIBC ( https://t.co/VQohcGz1JE ) = Neoadjuvant ICI + in situ vaccination (SBRT) in Cis-Ineligible MIBC. Thx to support from @sonpavde NEsnoala @TimBooneMDPhD @EfstathiouEleni @JennyCChang1 ! @BladderCancerUS
-
Superstition in Surgery - Should we operate on Friday the 13th? https://t.co/wKhqxm3PAH @SanjanaR2024 @WallisCJD